Mitigation of secondary disease in mice receiving bone marrow from donors pretreated with cortisone and alkylating agents.
D000818:Animals; D000917:Antibody Formation; D001853:Bone Marrow / Q000187:drug effects; D001854:Bone Marrow Cells; D016026:Bone Marrow Transplantation; D003348:Cortisone / Q000494:pharmacology; D008214:Lymphocytes / Q000187:drug effects; D051379:Mice; D009588:Nitrogen Mustard Compounds / Q000494:pharmacology; D011878:Radiotherapy; D014181:Transplantation Immunology; D014184:Transplantation, Homologous / Q000009:adverse effects*; D005719:gamma-Globulins / Q000096:biosynthesis
D009588:Nitrogen Mustard Compounds; D005719:gamma-Globulins; D003348:Cortisone